The present invention is directed to an anti-cancer drug containing an anti-MFG-E8 antibody as an active ingredient, and to an anti-cancer drug which employs an anti-MFG-E8 antibody in combination with a cancer therapy employing an anti-cancer agent other than the anti-MFG-E8 antibody. The separation chamber has first and second end portions, with the first end portion being operably oriented gravitationally above the second end portion. The component connector includes a base and a cap, wherein the cap releasably connected to the base. The polymerization solution has a temperature of less than about 20\xb0 C. The generator mechanism has a coil mounted to the hub shaft and a magnet unit disposed such that the generator mechanism generates electric power via the rotation of the hub shell relative to the hub shaft. The prisms are displaced using a mobile system with a single degree of freedom, comprising two support elements and at least two rotatably hinged levers.